Dr Willem-Jan Krebber | COO
I.S.A. Therapeutics Bv

Dr Willem-Jan Krebber, COO, I.S.A. Therapeutics Bv

Willem-Jan Krebber, Chief Operating Officer
Willem-Jan Krebber has over 15 years of experience in the pharmaceutical and biotechnology industry in various roles covering process development, manufacturing and project management. In his current role as Chief Operating Officer he leads all innovation, product development and manufacturing activities within the company. Prior to ISA Pharmaceuticals, he worked at OctoPlus (now Dr. Reddy's R&D) as CMC Program Manager where he was responsible for managing OctoPlus own product and technology development programs on advanced drug formulations and delivery. Prior to OctoPlus he held various CMC and project management positions at Crucell (now part of Janssen Vaccines & Prevention and Johnson & Johnson) for the development and manufacturing of cell-based products. Willem-Jan Krebber holds a Masters in Biology from Utrecht University and a Masters in Biotechnology from Delft University of Technology.

Appearances:



Day One 10th Oct Human, Vet, Immune @ 15:45

Data supporting the value of check point inhibitors, AMPLIVANT SLP conjugates and neoantigens in combinational immunotherapy against HPV cancers

back to speakers